4 ML bevacizumab-awwb 25 MG/ML Injection [Mvasi]
- RxCUI
- 2046149
- RxNorm name
- 4 ML bevacizumab-awwb 25 MG/ML Injection [Mvasi]
- Display name
- 4 ML bevacizumab-awwb 25 MG/ML Injection [Mvasi]
- Full name
- 4 ML bevacizumab-awwb 25 MG/ML Injection [Mvasi]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761028 | Mvasi | bevacizumab-awwb | 351(k) Biosimilar | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MVASI | BEVACIZUMAB-AWWB | Amgen, Inc | 0a562b4e-67ce-4bab-852c-d9ee71e55fb8 | 2026-06-23 | Warnings, Adverse reactions | 2046149 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0a562b4e-67ce-4bab-852c-d9ee71e55fb8 | MVASI 100 MG in 4 ML Injection [PSN] · 4 ML bevacizumab-awwb 25 MG/ML Injection [Mvasi] [SBD] · 4 ML Mvasi 25 MG/ML Injection [SY] · Mvasi 100 MG per 4 ML Injection [SY] | 4 | 22 | These highlights do not include all the information needed to use MVASI safely and effectively. See full prescribing information for MVASI. MVASI ® (bevacizumab-awwb) injection, for intravenous use Initial U.S. Approval: 2017 MVASI (bevacizumab-awwb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the | 20260310 |